Scarica l'app Stockscreener
1.48
4.52%
-0.07
Dopo l'orario di chiusura:
1.48
Precedente Chiudi:
$1.55
Aprire:
$1.55
Volume 24 ore:
126.37K
Relative Volume:
0.14
Capitalizzazione di mercato:
$38.90M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+6.47%
1M Prestazione:
+18.40%
6M Prestazione:
-21.28%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$1.425
$1.55
Intervallo di 1 settimana:
$1.36
$1.56
Portata 52W:
$1.04
$3.50
Rein Therapeutics Inc Stock (RNTX) Company Profile
Nome
Rein Therapeutics Inc
Settore
Industria
Telefono
(737) 802-1989
Indirizzo
12407 N. MOPAC EXPY., AUSTIN
Confronta RNTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RNTX
Rein Therapeutics Inc
|
1.48 | 40.74M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-22 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2017-07-24 | Iniziato | BofA/Merrill | Buy |
| 2017-07-24 | Iniziato | Jefferies | Buy |
| 2017-07-24 | Iniziato | William Blair | Outperform |
Rein Therapeutics Inc Borsa (RNTX) Ultime notizie
White House AI Czar Defends Trump Push to Rein In State Rules - Yahoo Finance
Rein Therapeutics ends agreements with Yorkville, incurs no penalties By Investing.com - Investing.com Nigeria
Rein Therapeutics ends agreements with Yorkville, incurs no penalties - Investing.com India
Rein Therapeutics Ends Key Financial Agreements - TipRanks
Rein Therapeutics ends key financial agreements - MSN
Rein Therapeutics Inc. (RNTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Rein Therapeutics Inc. stock attractive for long term wealth building2025 Winners & Losers & Comprehensive Market Scan Insights - Newser
Is Rein Therapeutics Inc. stock positioned well for digital economyAnalyst Upgrade & Low Drawdown Investment Strategies - Newser
Hedge Fund Bets: Can Rein Therapeutics Inc stock attract ESG capital inflowsJuly 2025 Price Swings & Daily Price Action Insights - BỘ NỘI VỤ
Bank Julius Baer & Co. Ltd Zurich Decreases Stock Position in Expedia Group, Inc. $EXPE - Defense World
Bank Julius Baer & Co. Ltd Zurich Sells 8,729 Shares of General Motors Company $GM - Defense World
Will Rein Therapeutics Inc. stock gain from strong economy - newser.com
Will Rein Therapeutics Inc. stock outperform Nasdaq indexMarket Movement Recap & Expert Curated Trade Setup Alerts - newser.com
Will Rein Therapeutics Inc. stock continue upward momentumJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
What drives Rein Therapeutics Inc stock priceVWAP Trading Strategies & Exceptional Growth Portfolio - earlytimes.in
Why retail investors favor Rein Therapeutics Inc. stockPortfolio Profit Report & Safe Capital Growth Tips - newser.com
Omdia: Middle East Smartphone Market up 23% in 3Q25; Supply Issues to Rein in 2026 Growth to 1% - Yahoo Finance
Voss capital reports $127k Rein Therapeutics (NASDAQ:RNTX) purchase By Investing.com - Investing.com South Africa
Voss capital reports $127k Rein Therapeutics (NASDAQ:RNTX) purchase - Investing.com India
How Rein Therapeutics Inc. stock reacts to bond yieldsWeekly Risk Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Will Rein Therapeutics Inc. stock maintain momentum in 2025Weekly Investment Recap & Expert Curated Trade Ideas - newser.com
Owner Voss Capital LP Buys 104,183 ($127.6K) Of Rein Therapeutics Inc [RNTX] - TradingView
Ranking Rein Therapeutics Inc. among high performing stocks via tools - newser.com
Comparing Rein Therapeutics Inc. in custom built stock radars2025 Bull vs Bear & Daily Oversold Bounce Ideas - newser.com
Price momentum metrics for Rein Therapeutics Inc. explained2025 Investor Takeaways & Expert Approved Trade Ideas - newser.com
Rein Therapeutics Inc Azioni (RNTX) Dati Finanziari
Non sono disponibili dati finanziari per Rein Therapeutics Inc (RNTX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Rein Therapeutics Inc Azioni (RNTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Voss Capital, LP | 10% Owner |
Oct 28 '25 |
Buy |
1.39 |
178,392 |
247,965 |
500,000 |
| Voss Capital, LP | 10% Owner |
Oct 27 '25 |
Buy |
1.37 |
97,482 |
133,544 |
822,258 |
| Voss Capital, LP | 10% Owner |
Oct 24 '25 |
Buy |
1.39 |
30,176 |
41,957 |
729,616 |
0.36%
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):